Suppose a new blood pressure pill enters the marketplace. It’s more effective than the next-best pill, in the sense that it reduces blood pressure to a greater extent. Therefore, we may presume, it’s likely to prevent more strokes and heart attacks. And it’s offered at the same price.
Therefore, cost-effectiveness analysis (CEA), comparing the two medic…
Keep reading with a 7-day free trial
Subscribe to Evaluation and Value for Investment to keep reading this post and get 7 days of free access to the full post archives.